BINDING OF [H-3] RO 16-6491, A REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B, TO HUMAN-BRAIN MITOCHONDRIA AND PLATELET MEMBRANES
BINDING OF [H-3] RO 16-6491, A REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B, TO HUMAN-BRAIN MITOCHONDRIA AND PLATELET MEMBRANES
复制标题
DOI:
10.1111/j.1471-4159.1987.tb13143.x
复制
发表时间:
1987-01-01
影响因子:
4.7
通讯作者:
DAPRADA, M
中科院分区:
文献类型:
--
作者:
CESURA, AM;GALVA, MD;DAPRADA, M
The reversible inhibitor of monoamine oxidase type B (MAO-B) [3H]Ro 16-6491 binds specifically and with high affinity to a single population of binding sites in human frontal cortex crude mitochondria and platelet membranes. In both tissues binding equilibrium was reached after 1 h incubation at 20.degree. C. Dissociation of bound radioactivity was relatively fast at 20.degree. C (t1/2 = 90-120 min) whereas at 0.degree. C [3H]Ro 16-6491 showed the characteristics of a slowly dissociating ligand. Inhibitors and substrates of MAO-B inhibited binding of [3H]Ro 16-6491, whereas MAO-A blockers were much less potent. Ro 16-6491 was also a substrate for MAO-B and a stable unidentified intermediate of the oxidation of Ro 16-6491 possessing high affinity for the enzyme may account for the marked MAO-B inhibitory effect of the drug. According to this hypothesis Ro 16-6491 would behave as a mechanism-based reversible inhibitor. In conclusion, [3H]Ro 16-6491 binds selectively to MAO-B and represents an excellent new radioligand probe for studing the regional tissue distribution of this enzyme in normal and pathological conditions.